Results 161 to 170 of about 1,438,673 (245)

Eye movement analysis detects early neurological alterations in cirrhotic patients classified as not having minimal hepatic encephalopathy by the Psychometric Hepatic Encephalopathy Score. [PDF]

PLoS One
Gallego JJ, Casanova-Ferrer F, Fiorillo A, López-Gramaje A, Campos D, Urios A, Megías J, San-Miguel T, Alcahuz-Griñán M, Durbán L, Kosenko E, García-Cena CE, Montoliu C.   +12 more
europepmc   +1 more source

Influence of Albumin Treatment Duration on Outcome of Terlipressin Therapy in Patients With HRS‐AKI

Liver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background and Aims Volume expansion with albumin is recommended to establish a diagnosis of hepatorenal syndrome–acute kidney injury (HRS‐AKI). The optimal duration of albumin administration is debated and requires balancing the risk of overtreatment with the need for timely diagnosis and treatment.
Eva Maria Schleicher, Christian Labenz, Frank Erhard Uschner, Julian Pohl, Moritz Passenberg, Michael Praktiknjo, Marcus Maximilian Mücke, Henrik Karbannek, Nina Böhling, Karsten Große, Marlene Reincke, Sarah Schütte, Paul Jamme, Julian Cardinal von Widdern, Christoph Welsch, Jonel Trebicka, Cornelius Engelmann, Jassin Rashidi‐Alavijeh, Cristina Ripoll, Dominik Bettinger, on behalf of the German cirrhosis study group, Johannes Chang, Maximilian Joseph Brol, Tony Bruns, Marko Damm, Jan Hendrik Harten, Christian Jansen, Alexander Queck, Christian Lange, Lauin Mustafa, Benjamin Maasoumy, Andreas Stallmach, Anna Teresa Volk, Alexander Zipprich   +33 more
wiley   +1 more source

Serum Hepatocyte Growth Factor Predicts Outcomes in Non‐Acetaminophen Drug‐Induced Acute Liver Failure

Liver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background and Aims Regenerative capacity and inflammatory responses are key determinants of outcome in acute liver failure (ALF). However, their prognostic significance in non‐acetaminophen drug‐induced liver injury with acute liver injury or ALF (non‐APAP‐DILI‐ALI/ALF) remains poorly defined.
Tao Wang, Silvia M. Bacot, Kamai Patterson, Devira Friedman, Caroline Taylor, Huixiao Hong, Jie Liu, Mark I. Avigan, Paul Hayashi, Jody A. Rule, William M. Lee, Jorge Rakela, Gerald M. Feldman, Minjun Chen   +13 more
wiley   +1 more source

Alterations in Oral Cecal Transit Time and Small Intestinal Microbiota in Minimal Hepatic Encephalopathy With Small Intestinal Bacterial Overgrowth. [PDF]

Clin Transl Gastroenterol
Cao L, Meng Y, Huang Y, Ye H, Han C, Liu X, Wu Y, Song Y, Wang Z, Cong Y, Wang L, Wang W, Wang Y, Zhao K, Wei H, Ren K, Mao Q, Cui M, Wang J, Cao B.   +19 more
europepmc   +1 more source

Identification of Prognostic Factors and Regulatory Pathways in Porto‐Sinusoidal Vascular Disorder

Liver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background and Aims Porto‐sinusoidal vascular disorder (PSVD) is a rare liver condition characterized by specific histological features primarily affecting the hepatic sinusoidal and periportal vasculature, in the absence of cirrhosis. This study aimed to identify prognostic factors and regulatory pathways associated with PSVD by integrating ...
Subin Heo, Do Kyung Yoon, Soyeon Shin, Dami Youn, Youngeun Yoo, In Hye Song, Hyo Jeong Kang, Young‐In Yoon, Kyunggon Kim, Seung Soo Lee, Sung Won Chung, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Mark Muthiah, Ho‐Su Lee, Won‐Mook Choi   +19 more
wiley   +1 more source

Comparison of probiotics to lactulose for minimal hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. [PDF]

Front Med (Lausanne)
He Q, Chen Z, Deng Y, Mao C, Fan Y.
europepmc   +1 more source

Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis. [PDF]

Clin Exp Hepatol, 2023
Wibawa IDN, Mariadi IK, Shalim CP, Sindhughosa DA.   +3 more
europepmc   +1 more source

Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With Cirrhosis

Liver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background & Aims YAQ001 is a novel, non‐absorbable, gut‐restricted, multiporous, carbon bead adsorbent. Pre‐clinical studies and a clinical trial suggested its therapeutic potential and safety in patients with cirrhosis. This substudy aimed to explore the effects of YAQ001 on the gut microbiome and their exploratory association with ...
Jinxia Liu, Fernando Garcia‐Guevara, Jane Macnaughtan, Yi Jin, Ainhoa Ferret‐Miñana, Frederick Clasen, Nicholas Yuen, Ramón Garcia Maset, Javier Ramón‐Azcón, Annarein J. C. Kerbert, Theo Portlock, Javier Martinez, Abeba Habtesion, Alexandra Phillips, Francesco De Chiara, Ganesh Ingavle, Tom Baldwin, Cesar Jimenez, Giacomo Zaccherini, Katherine Husi, Miguel Rodriguez‐Gandia, Paul Cordero‐Sanchez, Junpei Soeda, Jude A. Oben, Karen Church, Jia V. Li, Aarti Jalan, Adria Juanola, Elsa Sola, Simon Eaton, Carrie Morgan, Thomas Avery, Michal Kowalski, Daniel Green, Amir Gander, Lindsey Ann Edwards, I. Jane Cox, Helena Cortez‐Pinto, Reiner Wiest, Francois Durand, Paolo Caraceni, Roberto Elosua, Joan Vila, Marco Pavesi, Vicente Arroyo, Nathan Davies, Rajeshwar P. Mookerjee, Susan Sandeman, Gautam Mehta, Julian R. Marchesi, Agustin Albillos, Jennifer L. Rohn, Fausto Andreola, Saeed Shoaie, Rajiv Jalan   +54 more
wiley   +1 more source

Detection of Minimal Hepatic Encephalopathy: Validation of Indonesian Norms for Psychometric Hepatic Encephalopathy Score

The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Saut Horas Hatoguan Nababan
doaj   +1 more source

Extracellular vesicles from plasma of patients with minimal hepatic encephalopathy induce neuroinflammation and cognitive impairment in rats, which are prevented by treating the patients with rifaximin. [PDF]

J Neuroinflammation
Lopez-Gramaje A, Arenas YM, Gallego JJ, Izquierdo-Altarejos P, Urios A, Escudero-García D, Benlloch S, Kosenko E, Felipo V, Montoliu C.   +9 more
europepmc   +1 more source